Recurrence rate in adjuvant local chemotherapy of bladder cancer with mitomycin C
Flüchter, S.H.; Harzmann, R.; Erdmann, D.; Bichler, K.H.
Helvetica Chirurgica Acta 49(3-4): 349-352
1982
ISSN/ISBN: 0018-0181 PMID: 6813293 Document Number: 187116
Document emailed within 1 workday
Related Documents
Ichihashi, H.; Yamauchi, M.; Watanabe, T.; Takagi, H.; Kondo, T. 1988: Prospective adjuvant chemotherapy of mitomycin C plus HCFU for colorectal cancer (2d report)--6-year survival after surgery: Tokai Cooperative Study Group of Surgical Adjuvant Chemotherapy Gan no Rinsho. Japan Journal of Cancer Clinics 34(4): 451-456Bar-Sela, G.; Tsalic, M.; Steiner, M.; Wollner, M.; Haim, N. 2009: Local recurrence following adjuvant chemotherapy without radiotherapy in completely resected stomach and gastroesophageal junction adenocarcinoma Anticancer Research 29(5): 1853-1856
Huncharek, M.; McGarry, R.; Kupelnick, B. 2001: Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis Anticancer Research 21(1b): 765-769
Takasaki, S.; Masumoto, N.; Tabata, H.; Nakamura, M.; Nakano, S.; Niho, Y. 1997: A case of colon cancer with local recurrence successfully treated by systemic and local intra-arterial chemotherapy using a combination of 5-fluorouracil, interferon-alpha 2A, leucovorin and carboplatin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(1): 109-113
Arima, S.; Ohsato, K.; Hisatsugu, T.; Shimura, H. 1994: Multicentre randomised study of adjuvant chemotherapy with mitomycin C and tegafur or tegafur-uracil in gastric cancer European Journal of Surgery 160(4): 227-232
Scher, H.I. 1990: Chemotherapy for invasive bladder cancer: neoadjuvant versus adjuvant Seminars in Oncology 17(5): 555-565
Flamm, J.; Grof, F. 1986: Adjuvant topical chemotherapy with cisplatin in superficial bladder cancer Der Urologe. Ausg. a 25(1): 48-50
Tada, Y.; Tabuchi, Y.; Nakamura, T.; Saitoh, Y. 1993: Prophylactic effects of mitomycin C (MMC) on the liver recurrence in a rabbit gastric VX2 cancer model with high frequency of the recurrence Nihon Geka Gakkai Zasshi 94(11): 1185-1193
Kida, K.; Shimizu, Y.; Ogawa, K.; Kanamaru, S.; Ito, N. 2018: Distant Metastasis in Patients with Non-Muscle Invasive Bladder Cancer without Local Recurrence : Report of Two Rare Cases Hinyokika Kiyo. Acta Urologica Japonica 64(6): 271-275
Uchino, T.; Mishima, H.; Osawa, T.; Matsumura, T.; Komaya, K.; Kimura, K.; Ando, K.; Saito, T.; Ishiguro, S.; Ohashi, N.; Arikawa, T.; Komatsu, S.; Miyachi, M.; Mizumatsu, S.; Sano, T. 2015: A Case of Local Recurrence and Lung Metastasis from a Rectal Cancer Treated with Systemic Chemotherapy and Cyberknife Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(12): 2276-2278
Takashi, M.; Murase, T.; Aota, Y.; Nagai, T.; Kinjo, T.; Sabashi, M.; Shimoji, T.; Miyake, K.; Hamajma, N.; Mizuno, S. 1988: Multivariate evaluation of survival factors and postoperative adjuvant chemotherapy in patients with bladder cancer treated by radical cystectomy Hinyokika Kiyo. Acta Urologica Japonica 34(8): 1377-1381
Splinter, T.A.; Denis, L.; Scher, H.I.; Schröder, F.H.; Dalesio, O. 1989: Neoadjuvant chemotherapy of invasive bladder cancer. The prognostic value of local tumor response Progress in Clinical and Biological Research 303: 541-547
Bollack, C.; Jacqmin, D.; Splinter, T.A.; De Pauw, M. 1988: Non-adjuvant chemotherapy of bladder neoplasms stage T3-4 using NO-x and MO. Preliminary results of the urogenital study group of the European Organization for Research and Treatment of Cancer Casopis Lekaru Ceskych 127(35): 1098-1100
Fietkau, R. 2001: Meta-analysis of preoperative radiotherapy for resectable rectal cancer: improvement of overall survival rate, tumor-specific survival rate and local recurrence control by preoperative radiotherapy Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 177(12): 681-682
Huland, H.; Otto, U. 1983: Mitomycin instillation to prevent recurrence of superficial bladder carcinoma. Results of a controlled, prospective study in 58 patients European Urology 9(2): 84-86
Punga-Maole, M.L.; Hubert, J.; Mangin, P. 1995: Bladder retraction, a complication of chemoprophylaxis of superficial bladder cancer using intravesical mitomycin C. Apropos of a case and review of the literature Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 5(4): 580-585
Del Zingaro, M.; Bruno, R.; Nunzi, E.; Porena, M.; Mearini, L. 2016: First and second transurethral resections in intermediate-high risk bladder cancer: impact of the surgeon's volume on the recurrence and progression of primary bladder cancer Minerva Urologica e Nefrologica 68(2): 194-203
Weber, W.; Laffer, U.; Metzger, U. 1993: Adjuvant portal liver infusion with 5-fluorouracil and mitomycin in colorectal cancer. SAKK Anticancer Research 13(5C): 1839-1840
Schmid, H.P.; Studer, U.E. 1997: Adjuvant chemotherapy after cystectomy for bladder tumors staged as superior or equal to pT3 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(1): 102-104
Neoptolemos, J.P.; Baker, P.; Beger, H.; Link, K.; Pederzoli, P.; Bassi, C.; Dervenis, C.; Friess, H.; Büchler, M. 1997: Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1) International Journal of Pancreatology: Official Journal of the International Association of Pancreatology 21(2): 97-104